Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Apr 21, 2026
First-line integration of Local Ablative Therapy (LAT) with EGFR Tyrosine Kinase Inhibitors (TKIs) in advanced EGFR+ NSCLC: A Systematic Review and Meta-Analysis.
AI Takeaway
Highlights the growing role of IP-led ablative techniques (like bronchoscopic or percutaneous ablation) in the management of oligoprogressive or oligometastatic lung cancer.